bpc 157 intervertebral disc degeneration study Comparing Rapid BPC-157 and Time Release for Gut Health Assessment of thoracic disc degeneration

According to the National Council on Aging, approximately 1 in 10 Americans aged 60+ have experienced some form of elder abuse, and most cases never get reported

Prevents fatty liver disease Enhances detoxification Improves cholesterol metabolism Supports bile production Who Benefits Most from MIC+B12

Lipids 1781 , 643654 (2008)

S.Fox-PowellM

Available: [8] Hudson Biotech, A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Pentadecapeptide BPC 157 for Accelerated Repair of Acute Grade II Hamstring Strain Confirmed by MRI, clinicaltrials.gov, Clinical trial registration NCT07437547, Feb

Observed Structural and Functional Outcomes Post-treatment evaluation revealed measurable changes, including: Increased intervertebral disc height (approximately 2025%) Reduction in herniation dimensions on MRI Improved spinal alignment Substantial functional improvement, with ODI scores decreasing from 70% to 20% While the authors emphasized that these findings represent observations from a single case, the results highlight why the intervertebral disc is considered a compelling target for regenerative research